01/13/2025
5:32 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:37 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SCHEDULE 13G/A | |
11/14/2024
10:44 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G/A | |
11/12/2024
3:49 PM | Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
09/16/2024
7:46 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:47 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:48 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
7:50 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:47 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:49 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
09/13/2024
3:49 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:50 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
3:57 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
3:05 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/12/2024
3:05 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
5:13 PM | Mereo BioPharma Group (Issuer)
PAKIANATHAN DEEPIKA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
5:35 PM | Mereo BioPharma Group (Subject)
PAKIANATHAN DEEPIKA (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
7:19 AM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2024
7:09 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
10:46 AM | JANUS HENDERSON GROUP PLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
06/27/2024
3:15 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:15 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:13 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:14 PM | Mereo BioPharma Group (Issuer)
Sermon Charles (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:15 PM | Mereo BioPharma Group (Issuer)
Scots-Knight Denise (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
5:21 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/24/2024
5:53 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
5:58 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144/A | |
06/24/2024
6:00 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/24/2024
6:04 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144/A | |
06/24/2024
6:04 PM | Lewicki John A. (Reporting)
Mereo BioPharma Group (Subject)
| Form 144/A | |
06/20/2024
3:27 PM | Mereo BioPharma Group (Subject)
Scots-Knight Denise (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:30 PM | Fox Christine Ann (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
06/20/2024
3:32 PM | Mereo BioPharma Group (Subject)
Sermon Charles (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2024
3:34 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
4:16 PM | Mereo BioPharma Group (Issuer)
Rosen David Efraim (Reporting)
Rubric Capital Management LP (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
3:30 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2024
8:15 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/27/2024
11:15 PM | Mereo BioPharma Group (Filer)
| Form EFFECT | |
05/23/2024
8:54 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:38 PM | Hughes-Wilson Alexandra (Reporting)
Mereo BioPharma Group (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024
3:16 PM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
3:49 PM | Mereo BioPharma Group (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/15/2024
3:19 PM | Mereo BioPharma Group (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2024
6:36 AM | Mereo BioPharma Group (Filer)
| Form ARS | |
04/24/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form DEF 14A | |
04/16/2024
1:58 PM | Mereo BioPharma Group (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13D/A | |
04/15/2024
6:30 AM | Mereo BioPharma Group (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
4:20 PM | Mereo BioPharma Group (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
5:51 PM | Mereo BioPharma Group (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
1:11 PM | Mereo BioPharma Group (Subject)
Rock Springs Capital Management LP (Filed by)
| Form SC 13G/A | |
02/14/2024
11:36 AM | MANGROVE PARTNERS IM, LLC (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
02/13/2024
4:26 PM | Mereo BioPharma Group (Subject)
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by)
| Form SC 13G/A | |
02/05/2024
4:09 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Mereo BioPharma Group (Subject)
| Form SC 13G | |
01/23/2024
3:16 PM | Mereo BioPharma Group (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
